SCHEMBL11840901

SCHEMBL11840901

CNC(=NO)NCc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX12 P18054 4/20 0.48
ALDH1A1 P00352 3/20 0.48
HPGD P15428 2/20 0.48
MAPT P10636 4/20 0.47
GAA P10253 4/20 0.47
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
POLB P06746 1/20 0.47
KDM4E B2RXH2 1/20 0.47
CYP3A4 P08684 1/20 0.47
IDO1 P14902 2/20 0.46
CA12 O43570 2/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
CA9 Q16790 2/20 0.46
GRIN2D O15399 2/20 0.44
GRIN3B O60391 2/20 0.44
GRIN1 Q05586 2/20 0.44
GRIN2A Q12879 2/20 0.44
GRIN2B Q13224 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11840897 1.00 ALOX12 (0.48) ALOX12ALDH1A1HPGDMAPTGAA
Bethanidine SCHEMBL34432 0.85 ALOX12 (0.48) ALOX12ALDH1A1HPGDMAPTGAA
Bethanidine SCHEMBL34434 0.85 ALOX12 (0.48) ALOX12ALDH1A1HPGDMAPTGAA
Bethanidine SCHEMBL34433 0.85 ALOX12 (0.48) ALOX12ALDH1A1HPGDMAPTGAA
Bethanidine SCHEMBL11505129 0.83 MAPT (0.50) ALOX12ALDH1A1HPGDMAPTGAA
SCHEMBL24797746 0.79 MCL1 (0.46) ALOX12ALDH1A1HPGDMAPTGAA
Bethanidine SCHEMBL122033 0.78 KMT2A (0.43) ALOX12ALDH1A1HPGDMAPTGAA
Bethanidine SCHEMBL122035 0.78 KMT2A (0.43) ALOX12ALDH1A1HPGDMAPTGAA
Bethanidine SCHEMBL29390473 0.78 KMT2A (0.43) ALOX12ALDH1A1HPGDMAPTGAA
Bethanidine SCHEMBL7530034 0.78 KMT2A (0.43) ALOX12ALDH1A1HPGDMAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-3954995-A Mono-and disubstituted hydroxyguanidines in the treatment of depression E. I. DU PONT DE NEMOURS AND COMPANY (US) 1976-05-04 US disclosed